Cargando…
Variability in CKD Biomarker Studies: Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Kidney Disease Progression in the Chronic Kidney Disease in Children (CKiD) Study
RATIONALE & OBJECTIVE: Biomarker studies are important for generating mechanistic insight and providing clinically useful predictors of chronic kidney disease (CKD) progression. However, variability across studies can often muddy the evidence waters. Here we evaluated real-world variability in b...
Autores principales: | Abraham, Alison G., Xu, Yunwen, Roem, Jennifer L., Greenberg, Jason H., Weidemann, Darcy K., Sabbisetti, Venkata S., Bonventre, Joseph V., Denburg, Michelle, Warady, Bradley A., Furth, Susan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515077/ https://www.ncbi.nlm.nih.gov/pubmed/34693253 http://dx.doi.org/10.1016/j.xkme.2021.04.007 |
Ejemplares similares
-
Association Between Chronic Kidney Disease–Mineral Bone Disease (CKD-MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKiD) Study
por: Yokoyama, Jennifer S., et al.
Publicado: (2020) -
Growth in Children with Autosomal Recessive Polycystic Kidney Disease in the CKiD Cohort Study
por: Hartung, Erum A., et al.
Publicado: (2016) -
Health and Dental Insurance and Health Care Utilization Among Children, Adolescents, and Young Adults With CKD: Findings From the CKiD Cohort Study
por: Molino, Andrea R., et al.
Publicado: (2022) -
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019) -
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)